Regencell Bioscience Holdings (RGC) Current Assets (2020 - 2025)

Regencell Bioscience Holdings has reported Current Assets for 6 years, with the latest figure at $2.4 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets changed N/A year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (changed N/A YoY), and the FY2025 full-year result was $4.9 million, up 1612.29% from the prior year.
• Current Assets for Q4 2025 stood at $2.4 million, down from $4.9 million in the prior quarter.
• The five-year high for Current Assets was $11.6 million in Q2 2023, with the low at -$1.6 million in Q2 2022.
• Historically, Current Assets has averaged $2.8 million across 5 years, with a median of $1.0 million in 2021.
• Annual changes were most pronounced in 2022 — Current Assets plunged 476.07% — and 2025, when it jumped 1612.29%.
• Regencell Bioscience Holdings' Current Assets stood at -$273285.0 in 2021, then sank by 476.07% to -$1.6 million in 2022, then soared by 838.18% to $11.6 million in 2023, then slumped by 102.79% to -$324198.0 in 2024, then surged by 827.09% to $2.4 million in 2025.
• The last three Current Assets figures came in at $2.4 million (Q4 2025), $4.9 million (Q2 2025), and -$324198.0 (Q2 2024), per Business Quant data.